Source: United States & Canada – South China Morning PostThe staff of the Food and Drug Administration said the benefits of Pfizer and BioNTech’s Covid-19 vaccine for young children likely outweigh its risks, ahead of a meeting next week where experts will weigh whether the shot should be cleared for use.According to the staff report, which was posted on the FDA website late Friday, the vaccine’s capacity to prevent hospitalisation and deaths likely exceed the risk of adverse outcomes such as the heart condition myocarditis, which has been reported…Read More